脑部PET-MRI系统市场依产品类型、技术、应用和最终用户划分－2025-2032年全球预测

预计到 2032 年，脑部 PET-MRI 系统市场规模将成长 113 亿美元，复合年增长率为 13.20%。

关键市场统计数据
基准年 2024	41.9亿美元
预计年份：2025年	47.5亿美元
预测年份 2032	113亿美元
复合年增长率 (%)	13.20%

脑部PET-MRI系统在临床卓越、研究进步与技术整合的策略重要性框架

脑部PET-MRI系统融合了功能性影像和构造成像，使临床医师和研究人员能够以更高的诊断信心应对复杂的神经系统疾病和肿瘤学挑战。透过将正子断层扫描的分子灵敏度与磁振造影卓越的软组织对比度相结合，这些混合平台能够增强病灶检测、表征肿瘤生物学特征，并提供多维度资讯以指导治疗方案的发展。随着临床路径的不断发展，混合影像技术透过实现疾病状态的早期检测、更好地区分肿瘤復发和治疗反应以及更精准的患者分层以进行标靶治疗，日益支持精准医疗的发展。

从研究角度来看，整合式影像技术能够同时获得互补生物标记物，减少配准误差，并实现将分子变化与结构和功能结果关联起来的纵向评估，从而加速转化研究。因此，学术中心和专科医院正在利用脑部PET-MRI技术来更好地了解神经退化性疾病，绘製癫痫代谢变化图谱，并改善放射性示踪剂的研发。因此，推动PET-MRI技术应用的因素不仅包括影像品质和通量，还包括与人工智慧主导的分析、放射组学流程和多模态资料管理系统的互通性，这些因素共同提升了PET-MRI的临床价值，并拓展了其应用场景。

科技进步与临床重点如何改变脑部PET-MRI格局并加速新型照护模式的出现

脑部PET-MRI系统正经历一场变革性的转变，主要得益于检测器技术、软体整合以及临床需求模式的进步。飞行时间成像技术、先进的MRI序列和混合重建演算法提高了信噪比和定量可靠性，从而能够更可靠地解读微小病灶和异质性组织环境。同时，围绕人工智慧和放射组学构建的软体生态系统正在简化影像分析工作流程，实现病灶的自动分割，并提取有价值的影像生物标记以支援预后建模。硬体和软体的进步正将脑部PET-MRI的效用从专业研究领域扩展到更广泛的临床应用领域。

此外，随着医疗服务提供者优先考虑以价值为导向的医疗服务和成本效益，营运模式也在不断演变。诊断影像科室正在寻求能够平衡影像品质、吞吐量、可维护性和生命週期成本的系统。供应商也积极回应，提供模组化平台、灵活的服务合约和资金筹措方案，以降低采用门槛。同时，监管和报销环境也在不断调整，以认可混合成像的临床优势，并鼓励开展能够证明改善患者预后和降低成本的试验。因此，医院和研究中心正在重新审视其资本配置策略，设备製造商、学术机构和临床网路之间也正在涌现新的合作模式，以加速混合成像技术的应用和临床检验。

评估美国2025年关税变化对脑部PET-MRI系统的采购、供应链和临床部署的累积影响

自2025年起生效的最新关税政策，增加了先进脑部PET-MRI系统的采购和部署难度。这些政策变化影响了关键子系统的进口成本，例如精密检测器、梯度线圈和电子元件，这些元件通常透过国际供应链采购。事实上，采购团队面临更长的前置作业时间和更高的采购价格，影响了资本支出週期和升级计画。因此，一些机构推迟了非紧急采购，而另一些机构则在探索替代筹资策略，以缓解短期预算压力。

除了直接的成本影响外，关税还在推动整个价值链上的策略性应对措施。供应商正在加快高成本零件的本地化生产，重新谈判供应商合同，并优先投资区域服务基础设施，以降低跨境关税的影响。医院和研究中心越来越倾向于寻求透明的总拥有成本模型和能够反映关税影响的保证。同时，财务团队正在重新考虑租赁和管理服务方案，以在不承担关税全部影响的情况下维持临床能力。总而言之，这些调整正在重塑采购决策标准，并推动先进影像处理技术全球筹资策略的重新评估。

细分洞察揭示了产品设计、成像技术、临床应用和最终用户需求如何影响脑部PET-MRI系统的采用。

产品配置在很大程度上决定了买家的偏好，整合式系统和串联式系统在工作流程和效能方面各有优劣。整合式系统适用于需要同时进行PET和MRI成像且能从整合式机架设计中获益的机构。在整合式系统中，高场系统和低场系统的差异进一步影响临床定位：高场系统优先考虑空间解析度和先进的光谱分析，而低场平台则强调成本效益和易于安装。相较之下，串联式系统提供连续式工作流程，在需要改装或分阶段投资的情况下更具优势。

技术选择也会影响临床适用性，尤其是在比较传统PET方法和飞行时间时。 TOF系统具有更高的灵敏度和定量能力，能够提高对微小病灶的检出率，并有助于复杂脑部造影场景的评估。应用主导的细分有助于明确用例的优先顺序。循环系统、神经科和肿瘤学需要客製化的影像通讯协定和示踪剂组合，其中肿瘤学用例又可进一步细分为转移性脑瘤脑肿瘤和原发性脑肿瘤，二者的诊断目标和治疗监测方式存在显着差异。最后，最终用户的特征也会影响采购和部署，因为诊断中心、医院和研究机构的营运模式和业务量预期各不相同。医院本身又分为私立和公立医院，它们的资本核准流程、报销框架和服务需求也各不相同。这些综合细分可以为供应商和医疗服务提供者的产品蓝图、服务模式和临床检验策略提供参考。

区域因素和竞争动态影响着世界主要地区的部署策略和临床重点。

监管环境、医疗保健资金筹措模式和研究强度方面的差异导致脑部PET-MRI系统的优先排序和使用有显着的区域差异。在美洲，这些系统往往集中在领先的学术医疗中心和拥有完善的研究和临床项目的三级医院，这些项目有望实现高性能成像和先进示踪剂的开发。因此，其实施策略着重于高通量、高级定量分析以及与製药和神经病学研究团队的合作。相较之下，欧洲、中东和非洲的情况则较为复杂，监管环境趋于统一，报销途径多样，基础设施成熟度也参差不齐，因此需要灵活的资金筹措和服务模式。在这些地区，供应商通常会寻求区域伙伴关係和本地化的培训项目，以促进临床应用并确保投资回报。

在亚太地区，对医疗基础设施的大力投资和不断扩展的研究网络正在加速技术的应用，但采购决策体现了成本敏感性和对尖端功能的需求之间的平衡。新兴中心优先考虑模组化解决方案，这些方案能够随着临床需求的增长，从基本的混合功能扩展到完全整合的高效能应用。在整个亚太地区，与医疗资讯技术系统的互通性、训练有素的技术人员和放射化学家的可用性以及临床支援仍然是成功应用的关键因素。因此，製造商和供应商必须根据每个地区独特的营运实际情况，调整其商业策略、服务布局和临床支援。

对脑部PET-MRI技术领域中影响创新、市场策略和服务模式的主要企业进行竞争和策略洞察

领先的供应商正透过平台性能、整合服务以及与临床和研究机构的策略伙伴关係来脱颖而出。产品蓝图强调提高检测器灵敏度、软体驱动的工作流程自动化以及降低安装复杂性并支援逐步升级的模组化架构。一些供应商将针对神经放射科医生和核医学专家的培训计画与强大的临床证据生成相结合，正获得临床认可，因为主导希望确保其新系统能够转化为可衡量的诊断和营运效益。

服务和资金筹措模式仍然是强而有力的竞争槓桿。提供以结果为导向的服务合约、远端监控和预测性维护的公司能够减少医院系统的停机时间，并降低整体营运风险。同时，与学术中心和示踪剂製造商建立策略联盟可以加速临床检验，并扩大支援的应用范围。在这种环境下，专注于特定领域的小型创新者，例如先进的重建演算法或紧凑型低场整合设计，可以透过提供与大型平台提供者整合的互补解决方案来占据特定细分市场。总而言之，竞争格局有利于那些将技术差异化与切实可行的支援解决方案以及主导商业化相结合的公司。

为製造商、医疗保健机构和投资者提供切实可行的优先建议，以加速脑部PET- 核磁共振造影系统的普及应用并最大限度地发挥其临床价值。

供应商应优先考虑产品设计的模组化，使医疗机构能够采用基准混合功能，并随着临床需求的成长扩展到更高阶的配置。投资于飞行时间性能、先进的重建软体以及与人工智慧分析的本地集成，将满足临床医生对更精准的病灶检测和更有效率的工作流程的需求。同时，製造商必须扩展区域服务网路并提供灵活的资金筹措模式，以简化采购流程并降低采购风险。这些战术性调整将缩短销售週期，并支援更广泛的临床应用。

医疗服务提供者和研发机构应制定多学科实施计划，让神经放射学、核子医学和肿瘤学相关人员儘早参与采购流程。建立本地示踪剂、标准化影像方案和结果追踪机制，将确保新系统带来可衡量的临床效益。投资者和系统购买者应针对地缘政治和关税相关风险，对供应商供应链和合约条款进行压力测试，同时支持能够分散风险和保护资本的管理服务模式。对于相关人员而言，优先透过前瞻性临床研究和真实世界註册研究来产生证据，对于获得有利的报销和促进长期应用至关重要。

一种透明的调查方法，描述了数据收集、检验和分析通讯协定，旨在为脑部PET- 核磁共振造影系统提供可靠的见解。

本分析整合了来自对医疗机构高管、影像科主任、临床研究人员和技术专家的访谈的原始研究，以及利用同行评审文献、监管文件和产品文檔进行的二手研究。透过将技术规范与临床试验结果和服务模式揭露进行交叉比对，对有关性能、吞吐量和营运要求的检验进行数据三角验证。在条件允许的情况下，也使用了多中心研究和已发表方案的实证证据来评估相对临床价值和推广应用障碍。

该调查方法还纳入了对采购流程、报销趋势和供应链韧性的定性评估，这些评估均来自与相关人员的咨询。我们承认存在一些限制：由于供应商数据为专有数据，且新兴技术在临床应用有限，因此需要谨慎推论和保守解读。为了减少偏差，我们从不同地区和不同类型的医疗机构收集专家观点，并对调查结果进行内部一致性审查，确保其与已记录的临床实践指南相符。这种透明的方法旨在提供可操作的信息，同时清晰地阐明我们结论所依据的假设和证据。

最后总结了混合脑造影技术下一步发展的策略重点、推广应用推动因素和实际考量。

脑部PET-MRI系统兼具临床需求和技术可行性，其独特的功能可提高诊断准确性并支持研究创新。随着供应商和医疗机构在高性能成像、灵活的资金筹措和强大的服务生态系统等方面达成共识，该系统的应用将持续加速。尤其是在神经病学和神经肿瘤学领域，分子数据和结构数据具有协同效应，临床专家和多学科团队在展现混合成像的价值并将其融入临床诊疗流程方面仍然至关重要。

展望未来，成功将取决于切实可行的策略，以应对供应链脆弱性、监管复杂性和劳动力准备。投资于证据生成、区域服务能力和互通软体生态系统的相关人员将更有能力将技术进步转化为常规临床效益。随着各机构不断调整其优先事项，那些采用灵活采购模式并与技术提供者建立策略合作伙伴关係的机构更有可能在创新和营运永续性之间取得平衡，从而使更多人能够享受到混合脑部造影带来的临床和研究益处。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 整合基于人工智慧的影像重建技术以提高脑部PET-MRI诊断的准确性
• 开发一种混合硅光电倍增器检测器，该探测器在脑部PET-MRI应用中实现了卓越的灵敏度
• 扩建7特斯拉超高场PET-MRI扫描仪，用于对神经退化性疾病进行详细研究
• 脑部PET-MRI研究中治疗反应监测的标准化定量生物标记的出现
• 将即时运动校正技术整合到脑部PET-MRI成像工作流程中，以减少伪影
• 学术和临床研究中心对紧凑、经济高效的脑部PET-MRI系统的需求日益增长
• 用于精确功能性代谢脑图谱绘製的同步飞行时间PET-MRI采集技术的进展
• 药厂和影像服务提供者合作，利用脑部PET-MRI加速药物试验评估。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 脑部PET-MRI系统市场（依产品类型划分）

• 整合系统
  • 高磁场系统
  • 低磁场系统
• 串联繫统

9. 依技术分類的脑部PET-MRI系统市场

• 传统的
• 飞行时间

第十章 脑部PET-MRI系统市场（依应用领域划分）

• 心臟病学
• 神经病学
• 肿瘤学
  • 转移性脑瘤
  • 原发性脑肿瘤

第十一章 脑部PET-MRI系统市场（依最终使用者划分）

• 诊断中心
• 医院
  • 私立医院
  • 公立医院
• 研究所

第十二章 脑部PET-MRI系统市场（依地区划分）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 脑部PET-MRI系统市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国脑部PET-MRI系统市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Siemens Healthineers AG
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips NV
  • United Imaging Healthcare Co., Ltd.
  • Neusoft Medical Systems Co., Ltd.
  • MR Solutions Ltd.
  • Mediso Ltd.
  • Bruker Corporation
  • Sofie Biosciences, Inc.
  • Aspect Imaging Ltd.

The Brain PET-MRI Systems Market is projected to grow by USD 11.30 billion at a CAGR of 13.20% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 4.19 billion
Estimated Year [2025]	USD 4.75 billion
Forecast Year [2032]	USD 11.30 billion
CAGR (%)	13.20%

Framing the strategic importance of brain PET-MRI systems for clinical excellence, research advancement, and technology integration

Brain PET-MRI systems represent a convergence of functional and structural imaging that enables clinicians and researchers to address complex neurological and oncological challenges with greater diagnostic confidence. By combining positron emission tomography's molecular sensitivity with magnetic resonance imaging's superior soft tissue contrast, these hybrid platforms offer multidimensional insights that enhance lesion detection, characterize tumor biology, and inform therapy planning. As clinical pathways evolve, hybrid imaging increasingly supports precision medicine approaches by enabling earlier detection of pathology, improved differentiation between tumor recurrence and treatment effects, and more informed patient stratification for targeted therapies.

From a research perspective, the integrated modality accelerates translational studies by facilitating simultaneous acquisition of complementary biomarkers, reducing registration errors, and enabling longitudinal assessments that link molecular changes with structural and functional outcomes. As a result, academic centers and specialized hospitals are leveraging brain PET-MRI to deepen understanding of neurodegenerative diseases, map metabolic alterations in epilepsy, and refine radiotracer development. Consequently, adoption decisions now hinge not only on image quality and throughput but also on interoperability with AI-driven analytics, radiomics pipelines, and multimodal data management systems, which collectively drive higher clinical value and expanded use cases.

How technological advances and clinical priorities are reshaping the brain PET-MRI landscape and accelerating new care models

The landscape for brain PET-MRI systems is undergoing transformative shifts driven by improvements in detector technology, software integration, and clinical demand patterns. Time-of-flight capabilities, advanced MRI sequences, and hybrid reconstruction algorithms have improved signal-to-noise ratios and quantitative reliability, enabling more confident interpretations in small lesions and heterogeneous tissue environments. Concurrently, software ecosystems built around artificial intelligence and radiomics are streamlining image analysis workflows, enabling automated lesion segmentation, and extracting high-value imaging biomarkers that support prognostic and predictive modeling. This combination of hardware and software progress is expanding the utility of brain PET-MRI from specialized research settings into broader clinical practice.

Additionally, operational models are evolving as providers prioritize value-based care and cost-effective utilization. Imaging departments seek systems that balance image quality with throughput, serviceability, and lifecycle costs. Vendors are responding by offering modular platforms, flexible service contracts, and financing solutions that lower the barrier to adoption. At the same time, the regulatory and reimbursement environment is adapting to recognize the clinical benefits of hybrid imaging, encouraging trials that demonstrate patient outcomes and cost offsets. As a result, hospitals and research centers are re-evaluating capital allocation strategies, and new collaborative models between device manufacturers, academic institutions, and clinical networks are emerging to accelerate adoption and clinical validation.

Evaluating the cumulative effects of United States tariff changes in 2025 on procurement, supply chains, and clinical deployment of brain PET-MRI systems

Recent tariff measures enacted in 2025 have introduced an additional layer of complexity into the procurement and deployment of advanced brain PET-MRI systems. These policy changes have affected import costs for key subsystems, including precision detectors, gradient coils, and electronic components, which are often sourced through international supply chains. In practice, procurement teams have encountered longer lead times and elevated purchase prices that influence capital expenditure cycles and refresh plans. Consequently, some institutions have deferred nonurgent purchases while others have sought alternative procurement strategies to mitigate short-term budgetary pressure.

Beyond direct cost implications, tariffs have catalyzed strategic responses across the value chain. Vendors have accelerated localization of manufacturing for high-cost components, renegotiated supplier contracts, and prioritized investments in regional service infrastructure to reduce exposure to cross-border tariffs. Hospitals and research centers are increasingly demanding transparent total-cost-of-ownership models and warranties that reflect tariff-induced volatility. Meanwhile, finance teams are revisiting leasing and managed-service alternatives to preserve clinical capacity without absorbing the full upfront tariff impact. Taken together, these adjustments are reshaping purchase decision criteria and driving a reevaluation of global sourcing strategies for advanced imaging technologies.

Segment-specific insights that reveal how product design, imaging technology, clinical applications, and end-user priorities shape adoption of brain PET-MRI systems

Product configuration explains a significant portion of buyer preference, with integrated systems and tandem systems offering distinct trade-offs in workflow and performance. Integrated systems appeal to centers that require simultaneous PET and MRI acquisition and benefit from consolidated gantry design; within integrated offerings, distinctions between high field and low field implementations further shape clinical positioning, with high field systems prioritizing spatial resolution and advanced spectroscopy while low field platforms emphasize cost-effectiveness and ease of siting. Tandem systems, by contrast, provide sequential workflows and can be advantageous where retrofitting or staged investment is preferred, enabling institutions to scale hybrid capability over time.

Technology choice also drives clinical suitability, particularly when considering conventional PET approaches versus time-of-flight-enabled systems. Time-of-flight enhances sensitivity and quantitation, improving detectability for small lesions and aiding in complex brain imaging scenarios. Application-driven segmentation clarifies use case priorities: cardiology, neurology, and oncology each demand tailored imaging protocols and tracer portfolios, and oncology use cases subdivide further into metastatic brain cancer and primary brain tumors where diagnostic objectives and therapeutic monitoring differ substantially. Finally, end-user characteristics influence purchasing and deployment, with diagnostic centers, hospitals, and research institutions exhibiting distinct operational models and volume expectations; hospitals themselves bifurcate into private and public establishments, reflecting divergent capital approval processes, reimbursement frameworks, and service delivery imperatives. When combined, these segmentation lenses inform product roadmaps, service models, and clinical validation strategies for suppliers and providers alike.

Regional considerations and competitive dynamics that influence deployment strategies and clinical priorities across major global territories

Regional context materially alters how brain PET-MRI systems are prioritized and utilized, with differences in regulatory landscapes, healthcare funding models, and research concentration shaping adoption timelines. In the Americas, systems tend to be concentrated in advanced academic medical centers and tertiary hospitals where integrated research and clinical programs expect high-performance imaging and sophisticated tracer development. As a result, deployment strategies emphasize throughput, advanced quantitation, and partnerships with pharmaceutical and neurology research groups. By contrast, Europe, Middle East & Africa presents a heterogeneous landscape in which regulatory harmonization, variable reimbursement pathways, and diverse infrastructure maturity require adaptable financing and service models. Here, vendors often pursue regional partnerships and localized training programs to accelerate clinical acceptance and ensure return on investment.

In the Asia-Pacific region, strong investment in healthcare infrastructure and expanding research networks are accelerating uptake, yet procurement decisions reflect a balance between cost sensitivity and aspirations for leading-edge capability. Emerging centers prioritize modular solutions that can scale from basic hybrid functionality toward fully integrated high-field performance as clinical demand grows. Across all regions, interoperability with health IT systems, availability of trained technologists and radiochemists, and the presence of clinical champions remain decisive factors in successful deployments. Consequently, manufacturers and providers must tailor commercial strategies, service footprints, and clinical support to align with the distinct operational realities of each region.

Competitive and strategic observations about leading companies shaping innovation, go-to-market approaches, and service models in brain PET-MRI technologies

Leading suppliers continue to differentiate through a combination of platform performance, integrated service offerings, and strategic partnerships with clinical and research institutions. Product roadmaps emphasize improvements in detector sensitivity, software-driven workflow automation, and modular configurations that reduce installation complexity and support incremental upgrades. Vendors that pair robust clinical evidence generation with targeted training programs for neuroradiologists and nuclear medicine specialists achieve greater clinical traction, as providers seek assurance that new systems will translate into measurable diagnostic and operational benefits.

Service and financing models remain powerful competitive levers. Companies that provide outcome-oriented service agreements, remote monitoring, and predictive maintenance reduce downtime and lower total operational risk for hospital systems. Meanwhile, strategic collaborations with academic centers and tracer manufacturers accelerate clinical validation and broaden the range of supported applications. In this environment, smaller innovators focused on niche capabilities such as advanced reconstruction algorithms or compact low-field integrated designs can capture specific segments by offering complementary solutions that integrate with larger platform providers. Overall, the competitive landscape rewards firms that combine technological differentiation with pragmatic support solutions and evidence-driven commercialization.

Practical and prioritized recommendations for manufacturers, healthcare providers, and investors to accelerate adoption and maximize clinical value from brain PET-MRI systems

Vendors should prioritize modularity in product design, enabling institutions to adopt baseline hybrid capability and scale to more advanced configurations as clinical demand grows. Investing in time-of-flight performance, advanced reconstruction software, and native integration with AI analytics will address clinician needs for improved lesion detectability and efficient workflows. Simultaneously, manufacturers must expand regional service networks and offer flexible financing models to mitigate procurement hurdles and reduce perceived acquisition risk. These tactical changes will shorten sales cycles and support broader clinical deployment.

Healthcare providers and research institutions should develop multidisciplinary implementation plans that align neuroradiology, nuclear medicine, and oncology stakeholders early in the procurement process. Establishing local tracer access, standardized imaging protocols, and outcome-tracking mechanisms will ensure that new systems deliver measurable clinical impact. Investors and system purchasers should stress-test vendor supply chains and contract terms against geopolitical and tariff-related risks, while endorsing managed-service approaches that distribute risk and preserve capital. Across stakeholders, prioritizing evidence generation through prospective clinical studies and real-world registries will be crucial to securing favorable reimbursement and driving long-term utilization.

Transparent research methodology explaining data collection, validation, and analysis protocols used to produce robust insights about brain PET-MRI systems

This analysis synthesizes primary insights from interviews with healthcare executives, imaging directors, clinical investigators, and technical experts, coupled with secondary research using peer-reviewed literature, regulatory filings, and product documentation. Data triangulation occurred by cross-referencing technical specifications with clinical trial outcomes and service model disclosures to validate claims about performance, throughput, and operational requirements. Wherever possible, empirical evidence from multi-center studies and published protocols informed assessments of relative clinical value and adoption hurdles.

The methodology also incorporates qualitative assessment of procurement processes, reimbursement trends, and supply chain resilience derived from stakeholder consultations. Limitations are acknowledged: proprietary vendor data and emerging technologies with limited clinical deployments required careful extrapolation and conservative interpretation. To mitigate bias, expert perspectives were sourced from diverse geographies and institutional types, and findings were reviewed for internal consistency and alignment with documented clinical practice guidelines. This transparent approach aims to deliver actionable intelligence while clearly communicating the assumptions and evidence underpinning the conclusions.

Closing synthesis that underscores strategic priorities, adoption enablers, and practical considerations for the next phase of hybrid brain imaging deployment

Brain PET-MRI systems stand at the intersection of clinical need and technological possibility, offering unique capabilities to improve diagnostic precision and support research innovation. Adoption will continue to accelerate where vendors and providers align on solutions that combine high-performance imaging, adaptable financing, and strong service ecosystems. Clinical champions and multidisciplinary teams will remain pivotal in demonstrating value and embedding hybrid imaging into care pathways, particularly in neurology and neuro-oncology applications where molecular and structural data synergize.

Looking ahead, success will depend on pragmatic strategies that address supply chain fragility, regulatory complexity, and workforce readiness. Stakeholders who invest in evidence generation, regional service capacity, and interoperable software ecosystems will be best positioned to convert technological advances into routine clinical benefit. As institutions refine their priorities, those that adopt flexible procurement models and that partner strategically with technology providers will achieve a balance between innovation and operational sustainability, enabling broader access to the clinical and research advantages of hybrid brain imaging.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Integration of AI powered image reconstruction techniques to enhance brain PET-MRI diagnostic accuracy
• 5.2. Development of hybrid silicon photomultiplier detectors for superior sensitivity in brain PET-MRI applications
• 5.3. Expansion of 7 Tesla ultra-high-field PET-MRI scanners for detailed neurodegenerative disease research
• 5.4. Emergence of standardized quantitative biomarkers for monitoring treatment response in brain PET-MRI studies
• 5.5. Integration of real-time motion correction technologies to reduce artifacts in brain PET-MRI imaging workflows
• 5.6. Growing demand for compact and cost effective brain PET-MRI systems in academic and clinical research centers
• 5.7. Advancements in simultaneous time-of-flight PET-MRI acquisition for precise functional metabolic brain mapping
• 5.8. Collaboration between pharmaceutical companies and imaging providers to accelerate brain PET-MRI drug trial assessments

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Brain PET-MRI Systems Market, by Product Type

• 8.1. Integrated Systems
  • 8.1.1. High Field Systems
  • 8.1.2. Low Field Systems
• 8.2. Tandem Systems

9. Brain PET-MRI Systems Market, by Technology

• 9.1. Conventional
• 9.2. Time Of Flight

10. Brain PET-MRI Systems Market, by Application

• 10.1. Cardiology
• 10.2. Neurology
• 10.3. Oncology
  • 10.3.1. Metastatic Brain Cancer
  • 10.3.2. Primary Brain Tumors

11. Brain PET-MRI Systems Market, by End User

• 11.1. Diagnostic Centers
• 11.2. Hospitals
  • 11.2.1. Private Hospitals
  • 11.2.2. Public Hospitals
• 11.3. Research Institutions

12. Brain PET-MRI Systems Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Brain PET-MRI Systems Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Brain PET-MRI Systems Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Share Analysis, 2024
• 15.2. FPNV Positioning Matrix, 2024
• 15.3. Competitive Analysis
  • 15.3.1. Siemens Healthineers AG
  • 15.3.2. GE HealthCare Technologies Inc.
  • 15.3.3. Koninklijke Philips N.V.
  • 15.3.4. United Imaging Healthcare Co., Ltd.
  • 15.3.5. Neusoft Medical Systems Co., Ltd.
  • 15.3.6. MR Solutions Ltd.
  • 15.3.7. Mediso Ltd.
  • 15.3.8. Bruker Corporation
  • 15.3.9. Sofie Biosciences, Inc.
  • 15.3.10. Aspect Imaging Ltd.

LIST OF FIGURES

• FIGURE 1. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 11. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. BRAIN PET-MRI SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. BRAIN PET-MRI SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. BRAIN PET-MRI SYSTEMS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HIGH FIELD SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HIGH FIELD SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HIGH FIELD SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HIGH FIELD SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HIGH FIELD SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HIGH FIELD SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY LOW FIELD SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY LOW FIELD SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY LOW FIELD SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY LOW FIELD SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY LOW FIELD SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY LOW FIELD SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TANDEM SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TANDEM SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TANDEM SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TANDEM SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TANDEM SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TANDEM SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CONVENTIONAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CONVENTIONAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CONVENTIONAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CONVENTIONAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TIME OF FLIGHT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TIME OF FLIGHT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TIME OF FLIGHT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TIME OF FLIGHT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TIME OF FLIGHT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TIME OF FLIGHT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CARDIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY CARDIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY NEUROLOGY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY METASTATIC BRAIN CANCER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY METASTATIC BRAIN CANCER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY METASTATIC BRAIN CANCER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY METASTATIC BRAIN CANCER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY METASTATIC BRAIN CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY METASTATIC BRAIN CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIMARY BRAIN TUMORS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 118. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 119. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 120. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 121. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 122. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 123. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 124. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 125. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 126. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 127. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 128. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 129. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 130. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 131. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 132. AMERICAS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 133. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 136. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 137. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 138. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 139. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 140. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 141. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 142. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 143. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 144. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 145. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 146. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 147. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 148. NORTH AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 149. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 150. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 151. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 152. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 153. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 154. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 155. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 156. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 157. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 158. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 159. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 160. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 161. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 162. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 163. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 164. LATIN AMERICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 165. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 166. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 167. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 168. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 169. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 170. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 181. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 182. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 183. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 184. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 185. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 186. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 187. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 188. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 189. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 190. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 191. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 192. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 193. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 194. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 195. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 196. EUROPE BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 197. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 198. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 199. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 200. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 201. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 202. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 203. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 204. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 205. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 206. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 207. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 208. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 209. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 210. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 211. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 212. MIDDLE EAST BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 213. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 214. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 215. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 216. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 217. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 218. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 219. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 220. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 221. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 222. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 223. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 224. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 225. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 226. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 227. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 228. AFRICA BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 229. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 230. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 231. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 232. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 233. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 234. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 235. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 236. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 237. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 238. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 239. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 240. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 241. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 242. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 243. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 244. ASIA-PACIFIC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 245. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 246. GLOBAL BRAIN PET-MRI SYSTEMS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 247. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 248. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 249. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 250. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 251. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 252. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 253. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 254. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 255. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 256. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 257. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 258. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 259. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 260. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 261. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 262. ASEAN BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 263. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 264. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 265. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 266. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 267. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 268. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 269. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 270. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 271. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 272. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 273. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 274. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 275. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 276. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 277. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 278. GCC BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 279. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 280. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 281. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 282. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 283. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 284. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 285. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 286. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 287. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 288. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 289. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 290. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 291. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 292. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 293. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 294. EUROPEAN UNION BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 295. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 296. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 297. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 298. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 299. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 300. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 301. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 302. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 303. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 304. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 305. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 306. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 307. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 308. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 309. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 310. BRICS BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 311. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 312. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 313. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 314. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 315. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 316. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 317. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 318. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 319. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 320. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 321. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 322. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 323. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 324. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 325. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 326. G7 BRAIN PET-MRI SYSTEMS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 327. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 328. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 329. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 330. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 331. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2018-2024 (USD MILLION)
• TABLE 332. NATO BRAIN PET-MRI SYSTEMS MARKET SIZE, BY INTEGRATED SYSTEMS, 2025-2032 (USD MILLION)
• TABLE 333. N